Search

everythinglearnresearchcommunity

for

Search:↓

TYK2 inhibition may help treat alopecia areata by promoting hair growth and reducing immune response.

Adenosine receptors could be promising targets for treating inflammatory skin diseases like psoriasis.

N-acetylcysteine may help treat trichotillomania.

Two new compounds can block androgen receptor activity in different ways and may lead to new treatments for androgen-related diseases.

A woman's shingles infection triggered her first episode of a rare neurological disorder and blood vessel inflammation.

Certain immune cells in atopic dermatitis skin could be targeted for treatment.

MCHR2 gene duplications may be linked to alopecia areata.

A new topical treatment for hair loss shows strong hair growth effects with low toxicity.

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.

Certain genetic variants in ERN1, TACR3, and SPPL2C are linked to when Alzheimer's disease starts.

Candida antigen is an effective and promising treatment for alopecia areata.

IMTA can help regrow hair in severe alopecia areata when JAK inhibitors don't work well.

Japanese researchers created new hair follicles from human cells that grew hair when put into mice, and other findings showed a link between eye disease severity and corneal thickness, gene mutations affecting hearing and touch, and the safety of the shingles vaccine for adults over 50.

New mutations in the SLC39A4 gene found in twins help understand the genetic cause of acrodermatitis enteropathica.

ChatGPT-4 can help with allergic contact dermatitis but shouldn't replace expert doctors.

New treatments for relapsing multiple sclerosis are more effective and convenient but have higher risks of serious side effects.

Dermal IgA deposition without symptoms is rare in Dermatitis herpetiformis risk groups.

Arg1+ macrophages may play a role in causing alopecia areata.

HLA can be linked to autoimmune hepatitis.

A brain-made hormone can protect against memory-related brain damage caused by harmful proteins.

A new method was developed to measure and assess the activity and inhibition of the enzyme steroid 5α-reductase.

The conclusion is that a treatment called cp-asiAR can reduce hair loss and promote hair growth, making it a potential new therapy for androgenetic alopecia.

Early diagnosis and treatment are crucial for CAPS, and Eculizumab can be effective.

Stress can cause a type of hair loss in mice lacking the CCHCR1 gene.

A woman with lupus and severe nerve damage improved with specific treatments.

A 6-year-old boy's skin condition improved after stopping a specific treatment and starting new medications.

A girl with a rare skin condition improved after one month of treatment with acitretin.

Lysophosphatidic acid affects sensory neurons and may cause neuropathic pain and itch.

Tildrakizumab significantly improved recalcitrant lichen planopilaris and frontal fibrosing alopecia.